Le Lézard
Classified in: Health
Subjects: LEG, POL, VET

Heritage Health Solutions Applauds Efforts to Establish a Department of Defense Substance Abuse Pilot Program


COPPELL, Texas, Sept. 18, 2019 /PRNewswire/ -- On September 12, 2019, the Senate Committee on Appropriations (Committee) voted to approve the Fiscal Year 2020 Department of Defense Appropriations bill.  Included in the report that accompanies this legislation is language urging the Department of Defense (DoD) to establish a health support and education pilot program to assist servicemembers who struggle with substance use disorders and other health challenges.

Heritage Health Solutions is the premier health care integrator headquartered in Coppell, Texas. We provide prescription drug and medical solutions to government entities, correctional facilities, and self-funded companies to improve patient care and reduce cost.

"As a true integrated health care manager, the team at Heritage Health Solutions works every day to assist our servicemembers and veterans with their health care and pharmacy needs.  We applaud the Senate Appropriations Committee for their support of those servicemembers and their families who need additional tools and resources to better handle issues related to their time in service to their country," said Tonya Clark, CEO of Heritage Health Solutions.

"We would like to thank Senator Jerry Moran of Kansas in particular for his continued leadership in ensuring that our military men, women and their families have the resources they need to deal with the challenges they face when returning from deployment or when they become injured or ill.  Senator Moran's support for this report language demonstrates his understanding of the need for innovative approaches to the unique and complex challenges our military members and veterans face every day," Clark said.

The Committee report accompanying the Fiscal Year 2020 Department of Defense Appropriations bill includes the following provision:

Substance Abuse Pilot Program?The Committee understands that wounded, ill, and injured servicemembers and their families face complicated and complex challenges, which at times can lead to attempts at self-medication and other substance use disorders. The Committee recognizes the need to provide opioid safety and substance use educational resources to at-risk servicemembers and their families in order to better prepare them for their warrior care and transition. As such, the Committee supports programs that utilize harm reduction techniques and offer confidential educational information that can reduce substance use, relapse, hospital visits, and suicide. The Committee encourages the Department to establish a health support and education pilot program at Army bases with transition units to provide servicemembers and their families with a comprehensive. Internet-based educational program and  tools related to substance use in order to assist and safeguard their warrior care and transition.

(PRNewsfoto/Heritage Health Solutions, Inc.)

SOURCE Heritage Health Solutions, Inc.


These press releases may also interest you

at 03:54
On May 9th, Momcozy, a global leader in mother and baby care, hosted a heartwarming event at Babylist Beverly Hills as part of its "Momcozy Village" campaign. This initiative emphasizes the belief that "it takes a village to raise a mother," focusing...

at 03:11
The eighth Aurora Prize for Awakening Humanity was awarded Thursday evening to Dr. Denis Mukwege, a world-renown gynecological surgeon and human rights activist from the Democratic Republic of the Congo (DRC). Dr. Mukwege is the president of Panzi...

at 03:05
Exact Sciences, a leading provider of cancer screening and diagnostic tests, today announced that the UK's National Institute for Health and Care Excellence (NICE) has recommended the expanded use of the Oncotype DX Breast Recurrence Score® test to...

at 03:00
Charging an electric vehicle (EV) at home is certainly more convenient than using a public charging station, but what are the other benefits? Along with convenience, the...

at 02:15
Announces co-exclusive licensing agreement with Sanofi to co-commercialize COVID-19 vaccine, develop novel COVID-19-Influenza combination vaccines and develop multiple new vaccines utilizing Novavax's Matrix-MTM adjuvantThis agreement represents a...

at 02:05
Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.; hereafter "Shionogi") and Maze Therapeutics, Inc. (Head Office: South San Francisco, California, USA; Chief Executive Officer: Jason Coloma, Ph.D.;...



News published on and distributed by: